Evaluation of the effects of red blood cell distribution width on survival in lung cancer patients by Mehmet Kos, Cemil Hocazade, F. Tugba Kos, Dogan Uncu, Esra Karakas, Mutlu Dogan, Hikmet G. Uncu, Nuriye Ozdemir, Nurullah Zengin

Get full text

“Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment? by Serkan Yaşar, Ahmet Kadıoğlu, Arif Akyildiz, Nadiye Sever, Mehmet Emin Büyükbayram, Mehmet Bilici, Elanur Karaman, Mehmet Uzun, Murat Bardakcı, Caglar Koseoglu, Irem Bilgetekin, Mehmet Cihan İçli, Alper Türkel, Zafer Arık, Murat Sarı, Tugba Yavuzsen, Mehmet Ali Nahit Sendur, İsmail Erturk, Mutlu Dogan

Get full text

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study by Neslihan Özyurt, Ali Alkan, Burcu Gülbağcı, Mustafa Seyyar, Esra Aşık, Mustafa Şahbazlar, Mehmet Türker, Oğuzcan Kınıkoğlu, Tahir Yerlikaya, Gülhan Dinç, Ali Aytaç, Ziya Kalkan, Senar Ebinç, İlkay Gültürk, Merve Keskinkılıç, Zehra Sucuoğlu İşleyen, Dilek Çağlayan, Alper Türkel, Esra Aydın, Teoman Şakalar, Serhat Sekmek, Nilgün Yıldırım, Sinem Koçak, Kerem Okutur, Ahmet Özveren, Bengü Dursun, Sait Kitaplı, Orhan Önder Eren, İsmail Beypınar, İlhan Hacıbekiroğlu, Devrim Çabuk, Elanur Karaman, Ömer Acar, Semra Paydaş, Melek Karakurt Eryılmaz, Bilgin Demir, Zeynep Oruç, Mesut Yılmaz, Fatih Selçuk Biricik, Derya Kıvrak Salim, Özgür Tanrıverdi, Mutlu Doğan

Get full text